." The New York Times <https://www.nytimes.com/2021/05/05/science/moderna-booster-variants-covid.html> (5/5, Mandavilli, 20.6M) reports Moderna CEO Stephane Bancel said of the results, "We are encouraged by these new data, which reinforce our confidence that our booster strategy should be protective against the

remdesivir and steroids are available." Moderna Says Its Vaccine Won't Be Ready Until Spring 2021. AXi0C (9/30, Knutson, 521K) reports Moderna CEO Stephane Bancel said Wednesday that his company's coronavirus vaccine "won't be available for widespread distribution until at least spring 2021." Bancel said the

wo weeks after the booster shots, and the trial is continuing to gather more data." The New York Times (5/5, Mandavilli, 20.6M) reports Moderna CEO Stephane Bancel said of the results, "We are encouraged by these new data, which reinforce our confidence that our booster strategy should be protective against th

In an interview with the New York Times <https://vvwvv.nytimes.com/2020/11/30/health/covid-vaccine- modema.html> (11/30, Grady, 18.61M), Moderna CEO Stephane Bancel announced the first vaccinations "may be given as early as Dec. 21 if the process goes smoothly and approval is granted." Bancel told the Wall Stree

remdesivir and steroids are available." Moderna Says Its Vaccine Won't Be Ready Until Spring 2021. Axios (9/30, Knutson, 521K) reports Moderna CEO Stephane Bancel said Wednesday that his company's coronavirus vaccine "won't be available for widespread distribution until at least spring 2021." Bancel said the

wo weeks after the booster shots, and the trial is continuing to gather more data." The New York Times (5/5, Mandavilli, 20.6M) reports Moderna CEO Stephane Bancel said of the results, "We are encouraged by these new data, which reinforce our confidence that our booster strategy should be protective against th

unced it received an additional $472 million from the U.S. government to support the development of its potential coronavirus vaccine." Moderna CEO Stephane Bancel indicated Monday that "the results from Moderna's late-stage trial could be released as soon as October." The AP (7/27, Neergaard, Hill) has more d

unced it received an additional $472 million from the U.S. government to support the development of its potential coronavirus vaccine." Moderna CEO Stephane Bancel indicated Monday that "the results from Moderna's late-stage trial could be released as soon as October." The AP (7/27, Neergaard, Hill) has more d

remdesivir and steroids are available." Moderna Says Its Vaccine Won't Be Ready Until Spring 2021. Axios (9/30, Knutson, 521K) reports Moderna CEO Stephane Bancel said Wednesday that his company's coronavirus vaccine "won't be available for widespread distribution until at least spring 2021." Bancel said the

a Officer Rolando Balsinde Director McKinsey & Company Spain Beat Balzli Editor-in-Chief HandelsZeitung and Switzerland Finanzrundschau AG Stephane Bancel Chief Executive Officer bioMerieux SA USA Oriana Bandiera Professor of Economics London School of Economics and Political Science United King